VOYA Investment Management
DSGN icon

VOYA Investment Management’s Design Therapeutics DSGN Stock Holding History

VOYA Investment Management’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,090
Closed -$37.3K – 2815
2023
Q4 		$37.3K Hold
14,090
– – ﹤0.01% 2874
2023
Q3 		$33.3K Hold
14,090
– – ﹤0.01% 2884
2023
Q2 		$88.8K Buy
14,090
+928
+7% +$5.68K ﹤0.01% 2822
2023
Q1 		$75.9K Hold
13,162
– – ﹤0.01% 2745
2022
Q4 		$135K Sell
13,162
-14,085
-52% -$191K ﹤0.01% 2683
2022
Q3 		$456K Buy
27,247
+14,675
+117% +$292K ﹤0.01% 2081
2022
Q2 		$176K Buy
+12,572
New +$170K ﹤0.01% 2447

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management's DSGN Position: Q1 2024 in Review

VOYA Investment Management sold out of Design Therapeutics (DSGN) in Q1 2024, closing a stake of 14,090 shares — an estimated $37.3K sold.

VOYA Investment Management first reported a position in DSGN in Q2 2022 and held it in 7 quarters. The position peaked at $456K in Q3 2022. 93 funds tracked by Wall St. Rank hold DSGN as of Q1 2024.

  • VOYA Investment Management reported no remaining Design Therapeutics position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 14,090 Design Therapeutics shares in Q1 2024, an estimated $37.3K.
  • VOYA Investment Management first reported a position in Design Therapeutics in Q2 2022 and held it in 7 quarters.
  • VOYA Investment Management's Design Therapeutics position peaked at $456K in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.